Protein microarray platform for the multiplex analysis of biomarkers in human sera

Teresa Urbanowska1, Sara Mangialaio, Christophe Zickler

  • 1Novartis Pharma AG Werk Klybeck, Postfach, CH-4002, Basel, Switzerland.

Summary

A novel protein microarray platform enables simultaneous, quantitative analysis of key inflammatory proteins like IL-1beta and TNFalpha. This validated technology offers a cost-effective and efficient method for biomarker monitoring in clinical studies.